Stellate Ganglion Block
Recruiting now · Phase 4
Conditions studied: Esophagectomy, Pneumonectomy, Lobectomy
In brief
The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.
Key facts
- Study ID
- NCT06271707
- Run by
- University of Minnesota
- People needed
- 48
- Starts
- 2025-05-19
- Expected to finish
- 2028-12-30
- Last updated by the study team
- 2026-08-10
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients undergoing esophagectomy, pneumonectomy, or lobectomy aged 18-85.
You may not qualify if…
- Patients who have an exclusion to regional anesthesia.
- Patients who have exclusion to stellate blockade.
- Patients who are pregnant assessed via self-report or pregnancy test if they have taken one
Where it is running
- University of Minnesota — Minneapolis, Minnesota, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.